IRS Misidentified $50M In Patent Litigation Costs, Mylan Says
The IRS wrongly denied a $50 million deduction to Mylan Inc. by incorrectly counting patent litigation costs as part of getting Food and Drug Administration approval to sell a generic drug, the...To view the full article, register now.
Already a subscriber? Click here to view full article